259 related articles for article (PubMed ID: 9009649)
1. Tinea capitis in adults.
Aste N; Pau M; Biggio P
Mycoses; 1996; 39(7-8):299-301. PubMed ID: 9009649
[TBL] [Abstract][Full Text] [Related]
2. Tinea capitis in children in the district of Cagliari, Italy.
Aste N; Pau M; Biggio P
Mycoses; 1997 Oct; 40(5-6):231-3. PubMed ID: 9476495
[TBL] [Abstract][Full Text] [Related]
3. Tinea capitis dermatophytes: susceptibility to antifungal drugs tested in vitro and in vivo.
Mock M; Monod M; Baudraz-Rosselet F; Panizzon RG
Dermatology; 1998; 197(4):361-7. PubMed ID: 9873175
[TBL] [Abstract][Full Text] [Related]
4. Tinea capitis in adults in southern Spain. A 17-year epidemiological study.
Lova-Navarro M; Gómez-Moyano E; Martínez Pilar L; Fernandez-Ballesteros MD; Godoy-Díaz DJ; Vera-Casaño A; Crespo-Erchiga V
Rev Iberoam Micol; 2016; 33(2):110-3. PubMed ID: 26774593
[TBL] [Abstract][Full Text] [Related]
5. Systemic antifungal therapy for tinea capitis in children.
Chen X; Jiang X; Yang M; González U; Lin X; Hua X; Xue S; Zhang M; Bennett C
Cochrane Database Syst Rev; 2016 May; 2016(5):CD004685. PubMed ID: 27169520
[TBL] [Abstract][Full Text] [Related]
6. Tinea capitis in adults in Tunisia.
Mebazaa A; Oumari KE; Ghariani N; Mili AF; Belajouza C; Nouira R; Denguezli M; Ben Said M
Int J Dermatol; 2010 May; 49(5):513-6. PubMed ID: 20534084
[TBL] [Abstract][Full Text] [Related]
7. Continuous increase of Trichophyton tonsurans as a cause of tinea capitis in the urban area of Paris, France: a 5-year-long study.
Gits-Muselli M; Benderdouche M; Hamane S; Mingui A; Feuilhade de Chauvin M; Guigue N; Picat MQ; Bourrat E; Petit A; Bagot M; Alanio A; Bretagne S
Med Mycol; 2017 Jul; 55(5):476-484. PubMed ID: 27744309
[TBL] [Abstract][Full Text] [Related]
8. The aetiological agents of tinea capitis in Zaragoza (Spain).
Rubio-Calvo C; Gil-Tomas J; Rezusta-Lopez A; Benito-Ruesca R
Mycoses; 2001; 44(1-2):55-8. PubMed ID: 11398641
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic efficacy of terbinafine in the treatment of three children with tinea tonsurans.
Desgarennes MD; Godoy MR; Palencia AB
J Am Acad Dermatol; 1996 Jul; 35(1):114-6. PubMed ID: 8682948
[No Abstract] [Full Text] [Related]
10. A randomized, double-blind, parallel-group, duration-finding study of oral terbinafine and open-label, high-dose griseofulvin in children with tinea capitis due to Microsporum species.
Lipozencic J; Skerlev M; Orofino-Costa R; Zaitz VC; Horvath A; Chouela E; Romero G; Gourmala N; Paul C;
Br J Dermatol; 2002 May; 146(5):816-23. PubMed ID: 12000378
[TBL] [Abstract][Full Text] [Related]
11. Changing face of tinea capitis in Europe.
Fuller LC
Curr Opin Infect Dis; 2009 Apr; 22(2):115-8. PubMed ID: 19262376
[TBL] [Abstract][Full Text] [Related]
12. Kerion Celsi: a clinical epidemiological study.
Aste N; Pau M; Biggio P
Mycoses; 1998; 41(3-4):169-73. PubMed ID: 9670770
[TBL] [Abstract][Full Text] [Related]
13. Tinea capitis due to Microsporum audouinii in Malta.
Vella Zahra L; Vella Briffa D
Mycoses; 2003; 46(9-10):433-5. PubMed ID: 14622396
[TBL] [Abstract][Full Text] [Related]
14. Pediatric tinea capitis caused by Trichophyton violaceum and Trichophyton soudanense in Rochester, Minnesota, United States.
Grigoryan KV; Tollefson MM; Olson MA; Newman CC
Int J Dermatol; 2019 Aug; 58(8):912-915. PubMed ID: 30548845
[TBL] [Abstract][Full Text] [Related]
15. A random comparative study of terbinafine versus griseofulvin in patients with tinea capitis in Western China.
Deng S; Hu H; Abliz P; Wan Z; Wang A; Cheng W; Li R
Mycopathologia; 2011 Nov; 172(5):365-72. PubMed ID: 21701791
[TBL] [Abstract][Full Text] [Related]
16. Treatment outcomes for tinea capitis in a skin of color population.
Bhanusali D; Coley M; Silverberg JI; Alexis A; Silverberg NB
J Drugs Dermatol; 2012 Jul; 11(7):852-6. PubMed ID: 22777228
[TBL] [Abstract][Full Text] [Related]
17. Systemic antifungal therapy for tinea capitis in children.
González U; Seaton T; Bergus G; Jacobson J; Martínez-Monzón C
Cochrane Database Syst Rev; 2007 Oct; (4):CD004685. PubMed ID: 17943825
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic options for the treatment of tinea capitis caused by Trichophyton species: griseofulvin versus the new oral antifungal agents, terbinafine, itraconazole, and fluconazole.
Gupta AK; Adam P; Dlova N; Lynde CW; Hofstader S; Morar N; Aboobaker J; Summerbell RC
Pediatr Dermatol; 2001; 18(5):433-8. PubMed ID: 11737692
[TBL] [Abstract][Full Text] [Related]
19. [Tinea capitis: clinical features and therapeutic alternatives].
Messina F; Walker L; Romero MLM; Arechavala AI; Negroni R; Depardo R; Marin E; Santiso GM
Rev Argent Microbiol; 2021; 53(4):309-313. PubMed ID: 33618899
[TBL] [Abstract][Full Text] [Related]
20. Griseofulvin versus terbinafine in the treatment of tinea capitis: a meta-analysis of randomized, clinical trials.
Fleece D; Gaughan JP; Aronoff SC
Pediatrics; 2004 Nov; 114(5):1312-5. PubMed ID: 15520113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
